Castleark Management LLC Acquires 295,712 Shares of Lam Research Corporation $LRCX

Castleark Management LLC increased its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 130.3% during the second quarter, HoldingsChannel reports. The institutional investor owned 522,650 shares of the semiconductor company’s stock after buying an additional 295,712 shares during the quarter. Lam Research accounts for about 1.5% of Castleark Management LLC’s investment portfolio, making the stock its 17th largest holding. Castleark Management LLC’s holdings in Lam Research were worth $50,875,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Lam Research by 1.1% during the second quarter. Vanguard Group Inc. now owns 130,609,265 shares of the semiconductor company’s stock worth $12,713,506,000 after purchasing an additional 1,457,163 shares during the last quarter. State Street Corp lifted its holdings in shares of Lam Research by 1.1% during the second quarter. State Street Corp now owns 59,551,547 shares of the semiconductor company’s stock worth $5,810,172,000 after purchasing an additional 629,666 shares during the period. JPMorgan Chase & Co. grew its position in shares of Lam Research by 14.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock valued at $3,954,188,000 after buying an additional 5,102,589 shares during the last quarter. Geode Capital Management LLC increased its position in Lam Research by 3.5% during the 2nd quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock valued at $3,280,484,000 after purchasing an additional 1,135,405 shares during the period. Finally, Norges Bank bought a new position in Lam Research during the second quarter worth $1,894,585,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on LRCX. Sanford C. Bernstein raised their price objective on shares of Lam Research from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Friday, November 21st. Hsbc Global Res raised Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Susquehanna boosted their target price on Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. B. Riley increased their price target on shares of Lam Research from $160.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, October 20th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research note on Monday, December 8th. Twenty-six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $152.87.

Insider Buying and Selling at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the transaction, the director owned 1,652 shares in the company, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 102,608 shares of company stock valued at $14,916,496. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Shares of LRCX opened at $160.52 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $169.69. The company has a market cap of $201.62 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77. The stock has a 50-day moving average price of $152.53 and a 200-day moving average price of $120.24.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s quarterly revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.